- Get link
- X
- Other Apps
This rating represents a strong Buy recommendation on the scale from 1 to 5 where 5 would mean strong sell 4 represents Sell 3 is Hold and 2 indicates Buy. The average price target is 000 with a high estimate of 000 and a low estimate of 000.
Covid Speculators Walking Away From Astrazeneca Azn
AstraZeneca plc AZN Stock Price.
Astrazeneca stock analysis. 4994 USD 044 089. Stock analysis for AstraZeneca PLC AZNLondon including stock price stock chart company news key statistics fundamentals and company profile. 5512 -009 -016 May 14 758 PM.
On average they anticipate AstraZenecas stock price to reach 9933 in the next year. Consensus on the Street is that AstraZeneca is a Moderate Buy based on 7 Buys 1 Hold and 1 Sell. Find the latest AstraZeneca PLC AZN stock analysis from Seeking Alphas top analysts.
34 rows AstraZeneca plc AZN Stock Price. All quotes are in local exchange time. This suggests a possible upside of 799 from the stocks.
Based on analysts offering 12 month price targets for AZN in the last 3 months. The average analyst price target of 66 implies 247 upside potential. According to 7 analysts the average rating for AstraZeneca stock is Buy The 12-month stock price forecast is 6360 which is an increase of.
The current price rise of ASTRAZENECA could raise concerns from investors as the firm it trading at a share price of 437800 on very low momentum in volume. Analysis on target price and performance of stocks is usually carefully studied by market experts and the current Wall Street consensus on AZN stock is a recommendation set at 150. See Astrazeneca PLC AZN stock analyst estimates including earnings and revenue EPS upgrades and downgrades.
However the British-Swedish drugmaker has been struggling for a few years with lower profitability as the company reported 134 billion in net income by the end of 2019 compared to 3 billion. Earnings vs Savings Rate. Earnings are expected to grow significantly over the next 3 years.
Exclusive research and insights from bulls and bears. Real-time last sale data for US. At the end of the latest market close AstraZeneca PLC AZN was valued at 5588.
5400 -010 -019 May 11 754 PM. 5521 USD 016 029 Updated May 14 2021 400 PM EDT - Market closed. AZNs forecast earnings growth 218 per year is above the savings rate 09.
14 brokerages have issued twelve-month price targets for AstraZenecas stock. Get the hottest stocks t. The company management teams may have good odds in positioning the firm resources to exploit market volatility in JuneThe stock standard deviation of daily returns for 90 days investing horizon is currently 1291.
AZNs earnings 218 per year are forecast to grow faster than the UK market 175 per year. AstraZeneca stock analysis AstraZeneca shares have been on an uptrend since early 2019 as prospects of a trade deal between the US and China help the stock to recoup some of its lost territory. AstraZeneca Stock Analysis Overview The AstraZeneca stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations Crowd Wisdom Hedge Fund Activity more.
The stock current value is 5628. 5410 USD -028 -051 Updated May 11 2021 400 PM EDT - Market closed. Their forecasts range from 6000 to 17500.
AstraZeneca plc AZN Stock Price. AstraZeneca plc AZN Stock Price. In that particular session Stock kicked-off at the price of 5549 while reaching the peak value of 5588 and lowest value recorded on the day was 5543.
AstraZeneca PLC ADR analyst estimates including AZN earnings per share estimates and analyst recommendations. 5505 USD 055 101 Updated May 13 2021 400 PM EDT - Market closed.
Covid Speculators Walking Away From Astrazeneca Azn
Astrazeneca Shares Jump Following Vaccine Approval
Astrazeneca Stock Vulnerable If Vaccine Falls Short Of High Bar Bloomberg
Astrazeneca Azn Shares Slump After 39 Billion Deal To Buy Alexion Bloomberg
Drug Wars How Astrazeneca Overtook Gsk In Uk Pharma Financial Times
Astrazeneca Stock Vulnerable If Vaccine Falls Short Of High Bar Bloomberg
Stock Of The Week Astrazeneca Morningstar
How Aztrazeneca Is Taking The Lead As Big Pharma Races To Produce A Covid 19 Vaccine Fortune
Astrazeneca Stock Jumps Despite Europe Covid Vaccine Woes Bloomberg
Doubts Raised Over Astrazeneca Oxford Vaccine Data Financial Times
Should Astrazeneca Be Your Next Coronavirus Buy The Motley Fool
Astrazeneca Gets Fda Priority Review For New Dose Of Imfinzi Cancer Drug
Priced To Perfection Astrazeneca Is A Sell Nasdaq Azn Seeking Alpha
What S The Outlook For Astrazeneca Stock The Motley Fool
Comments
Post a Comment